In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Public offering nets $109.3mm for Tandem Diabetes

Executive Summary

Tandem Diabetes Care Inc. (manufactures and sells insulin pumps and glucose monitoring devices) netted $109.3mm through the public sale of 4mm common shares (including the overallotment) at $28.50. The company will use some or all of the proceeds to repay debt under an existing term loan agreement with Capital Royalty.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies